Literature DB >> 24767873

Plasmacytoid dendritic cell depletion in DOCK8 deficiency: rescue of severe herpetic infections with IFN-α 2b therapy.

Sevgi Keles1, Haifa H Jabara2, Ismail Reisli3, Douglas R McDonald2, Isil Barlan4, Rima Hanna-Wakim5, Ghassan Dbaibo5, Gerard Lefranc6, Waleed Al-Herz7, Raif S Geha2, Talal A Chatila8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24767873      PMCID： PMC4052613          DOI： 10.1016/j.jaci.2014.03.032

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  9 in total

1.  DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses.

Authors:  Yosuke Harada; Yoshihiko Tanaka; Masao Terasawa; Markus Pieczyk; Katsuyoshi Habiro; Tomoya Katakai; Kyoko Hanawa-Suetsugu; Mutsuko Kukimoto-Niino; Tomoko Nishizaki; Mikako Shirouzu; Xuefeng Duan; Takehito Uruno; Akihiko Nishikimi; Fumiyuki Sanematsu; Shigeyuki Yokoyama; Jens V Stein; Tatsuo Kinashi; Yoshinori Fukui
Journal:  Blood       Date:  2012-03-28       Impact factor: 22.113

2.  Hyper-IgE syndrome with widespread premalign oral papillomas treated with interferon alpha2b.

Authors:  Güzin Ozarmağan; Kurtulus Didem Yazganoğlu; Ali Agaçfidan
Journal:  Acta Derm Venereol       Date:  2005       Impact factor: 4.437

Review 3.  Plasmacytoid dendritic cells: recent progress and open questions.

Authors:  Boris Reizis; Anna Bunin; Hiyaa S Ghosh; Kanako L Lewis; Vanja Sisirak
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

4.  Defective actin accumulation impairs human natural killer cell function in patients with dedicator of cytokinesis 8 deficiency.

Authors:  Melissa C Mizesko; Pinaki P Banerjee; Linda Monaco-Shawver; Emily M Mace; William E Bernal; Julie Sawalle-Belohradsky; Bernd H Belohradsky; Valerie Heinz; Alexandra F Freeman; Kathleen E Sullivan; Steven M Holland; Troy R Torgerson; Waleed Al-Herz; Janet Chou; Imelda C Hanson; Michael H Albert; Raif S Geha; Ellen D Renner; Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2013-02-04       Impact factor: 10.793

5.  Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome.

Authors:  Karin R Engelhardt; Sean McGhee; Sabine Winkler; Atfa Sassi; Cristina Woellner; Gabriela Lopez-Herrera; Andrew Chen; Hong Sook Kim; Maria Garcia Lloret; Ilka Schulze; Stephan Ehl; Jens Thiel; Dietmar Pfeifer; Hendrik Veelken; Tim Niehues; Kathrin Siepermann; Sebastian Weinspach; Ismail Reisli; Sevgi Keles; Ferah Genel; Necil Kutukculer; Necil Kutuculer; Yildiz Camcioğlu; Ayper Somer; Elif Karakoc-Aydiner; Isil Barlan; Andrew Gennery; Ayse Metin; Aydan Degerliyurt; Maria C Pietrogrande; Mehdi Yeganeh; Zeina Baz; Salem Al-Tamemi; Christoph Klein; Jennifer M Puck; Steven M Holland; Edward R B McCabe; Bodo Grimbacher; Talal A Chatila
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

6.  Combined immunodeficiency associated with DOCK8 mutations.

Authors:  Qian Zhang; Jeremiah C Davis; Ian T Lamborn; Alexandra F Freeman; Huie Jing; Amanda J Favreau; Helen F Matthews; Joie Davis; Maria L Turner; Gulbu Uzel; Steven M Holland; Helen C Su
Journal:  N Engl J Med       Date:  2009-09-23       Impact factor: 91.245

7.  DOCK8 is critical for the survival and function of NKT cells.

Authors:  Greg Crawford; Anselm Enders; Uzi Gileadi; Sanda Stankovic; Qian Zhang; Teresa Lambe; Tanya L Crockford; Helen E Lockstone; Alexandra Freeman; Peter D Arkwright; Joanne M Smart; Cindy S Ma; Stuart G Tangye; Christopher C Goodnow; Vincenzo Cerundolo; Dale I Godfrey; Helen C Su; Katrina L Randall; Richard J Cornall
Journal:  Blood       Date:  2013-08-08       Impact factor: 22.113

8.  DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice.

Authors:  Katrina L Randall; Stephanie S-Y Chan; Cindy S Ma; Ivan Fung; Yan Mei; Mehmet Yabas; Andy Tan; Peter D Arkwright; Wafaa Al Suwairi; Saul Oswaldo Lugo Reyes; Marco A Yamazaki-Nakashimada; Maria de la Luz Garcia-Cruz; Joanne M Smart; Capucine Picard; Satoshi Okada; Emmanuelle Jouanguy; Jean-Laurent Casanova; Teresa Lambe; Richard J Cornall; Sarah Russell; Jane Oliaro; Stuart G Tangye; Edward M Bertram; Christopher C Goodnow
Journal:  J Exp Med       Date:  2011-10-17       Impact factor: 14.307

9.  DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation.

Authors:  Haifa H Jabara; Douglas R McDonald; Erin Janssen; Michel J Massaad; Narayanaswamy Ramesh; Arturo Borzutzky; Ingrid Rauter; Halli Benson; Lynda Schneider; Sachin Baxi; Mike Recher; Luigi D Notarangelo; Rima Wakim; Ghassan Dbaibo; Majed Dasouki; Waleed Al-Herz; Isil Barlan; Safa Baris; Necil Kutukculer; Hans D Ochs; Alessandro Plebani; Maria Kanariou; Gerard Lefranc; Ismail Reisli; Katherine A Fitzgerald; Douglas Golenbock; John Manis; Sevgi Keles; Reuben Ceja; Talal A Chatila; Raif S Geha
Journal:  Nat Immunol       Date:  2012-05-13       Impact factor: 25.606
  9 in total
  21 in total

1.  Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum.

Authors:  Lianghua Bin; Michael G Edwards; Ryan Heiser; Joanne E Streib; Brittany Richers; Clifton F Hall; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2014-08-23       Impact factor: 10.793

2.  Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes TH17 cell differentiation.

Authors:  Sevgi Keles; Louis Marie Charbonnier; Venkataraman Kabaleeswaran; Ismail Reisli; Ferah Genel; Nesrin Gulez; Waleed Al-Herz; Narayanaswamy Ramesh; Antonio Perez-Atayde; Neslihan E Karaca; Necil Kutukculer; Hao Wu; Raif S Geha; Talal A Chatila
Journal:  J Allergy Clin Immunol       Date:  2016-05-24       Impact factor: 10.793

Review 3.  Insights into immunity from clinical and basic science studies of DOCK8 immunodeficiency syndrome.

Authors:  Helen C Su; Huie Jing; Pam Angelus; Alexandra F Freeman
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

Review 4.  RHO GTPases: from new partners to complex immune syndromes.

Authors:  Rana El Masri; Jérôme Delon
Journal:  Nat Rev Immunol       Date:  2021-02-05       Impact factor: 53.106

Review 5.  DOCK8 deficiency: Insights into pathophysiology, clinical features and management.

Authors:  Catherine M Biggs; Sevgi Keles; Talal A Chatila
Journal:  Clin Immunol       Date:  2017-06-15       Impact factor: 3.969

6.  DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients.

Authors:  Susanne E Aydin; Sara Sebnem Kilic; Caner Aytekin; Ashish Kumar; Oscar Porras; Leena Kainulainen; Larysa Kostyuchenko; Ferah Genel; Necil Kütükcüler; Neslihan Karaca; Luis Gonzalez-Granado; Jordan Abbott; Daifulah Al-Zahrani; Nima Rezaei; Zeina Baz; Jens Thiel; Stephan Ehl; László Marodi; Jordan S Orange; Julie Sawalle-Belohradsky; Sevgi Keles; Steven M Holland; Özden Sanal; Deniz C Ayvaz; Ilhan Tezcan; Hamoud Al-Mousa; Zobaida Alsum; Abbas Hawwari; Ayse Metin; Susanne Matthes-Martin; Manfred Hönig; Ansgar Schulz; Capucine Picard; Vincent Barlogis; Andrew Gennery; Marianne Ifversen; Joris van Montfrans; Taco Kuijpers; Robbert Bredius; Gregor Dückers; Waleed Al-Herz; Sung-Yun Pai; Raif Geha; Gundula Notheis; Carl-Philipp Schwarze; Betül Tavil; Fatih Azik; Kirsten Bienemann; Bodo Grimbacher; Valerie Heinz; H Bobby Gaspar; Roland Aydin; Beate Hagl; Benjamin Gathmann; Bernd H Belohradsky; Hans D Ochs; Talal Chatila; Ellen D Renner; Helen Su; Alexandra F Freeman; Karin Engelhardt; Michael H Albert
Journal:  J Clin Immunol       Date:  2015-01-28       Impact factor: 8.317

Review 7.  Current Status of Dedicator of Cytokinesis-Associated Immunodeficiency: DOCK8 and DOCK2.

Authors:  Dimana Dimitrova; Alexandra F Freeman
Journal:  Dermatol Clin       Date:  2017-01       Impact factor: 3.478

Review 8.  Primary immunodeficiency update: Part I. Syndromes associated with eczematous dermatitis.

Authors:  Dominique C Pichard; Alexandra F Freeman; Edward W Cowen
Journal:  J Am Acad Dermatol       Date:  2015-09       Impact factor: 11.527

Review 9.  Recent Advances in DOCK8 Immunodeficiency Syndrome.

Authors:  Qian Zhang; Huie Jing; Helen C Su
Journal:  J Clin Immunol       Date:  2016-05-20       Impact factor: 8.317

10.  Successful interferon-alpha 2b therapy for unremitting warts in a patient with DOCK8 deficiency.

Authors:  Talal A Chatila; Raif Geha; Daifulah Al-Zahrani; Ali Raddadi; Michel Massaad; Sevgi Keles; Haifa H Jabara
Journal:  Clin Immunol       Date:  2014-04-15       Impact factor: 3.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.